Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Committees and advisory bodies (384)
- (-) Safety monitoring and information (27)
- Scheduling (national classification system) (166)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
400 result(s) found, displaying 151 to 175
-
Meeting statementsTherapeutic Goods Advertising Consultative Committee, 21 March 2022 communique
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 31, 8 February 2022
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 30, 14 January 2022
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 29, 7 January 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 April 2022
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement, Meeting 65, 10 February 2022
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement, Meeting 64, 9 December 2021
-
Scheduling decisions (final)Final decision on proposed amendment to the Poisons Standard relating to sodium nitrite (Joint ACMS-ACCS #28, June 2021)
-
Meeting statementsAdvisory Committee on Vaccines, meeting 28, 22 December 2021
-
Meeting statementsAdvisory Committee on Medicines, meeting statement now available
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 27, 1 December 2021
-
TGA laboratory testing reportsIn consultation with the TGA, Edgewell has taken a precautionary approach and commenced a recall of all batches of these three products from the Australian market.
-
Meeting statementsA meeting of the TGACC was held 6 December 2021. The Communique has now been published.
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard.
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACMS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 Joint ACMS-ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 Joint ACMS-ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACMS meeting
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard relating to MDMA and psilocybin.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed 1 November 2021.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed: 11 November 2021
-
Meeting statementsAdvisory Committee on Vaccines. Meeting statement available.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement available.